1071608-51-9 Usage
Chemical structure
1-Piperazinyl(2-pyridinyl)methanone hydrochloride is a heterocyclic compound that contains a piperazine ring and a pyridine ring.
Solubility and stability
The hydrochloride salt form of this compound improves its solubility and stability, making it suitable for use in medicinal formulations.
Therapeutic potential
1-Piperazinyl(2-pyridinyl)methanone hydrochloride is used in the pharmaceutical industry for its potential therapeutic effects.
Applications
It may have applications in the treatment of various diseases and disorders, making it a subject of interest in drug discovery and development.
Chemical properties
As a derivative of piperazine, 1-Piperazinyl(2-pyridinyl)methanone hydrochloride may exhibit similar chemical properties, such as reactivity and binding affinity.
Pharmacological activities
The potential pharmacological activities of 1-Piperazinyl(2-pyridinyl)methanone hydrochloride are not yet fully understood, but it is of interest in drug discovery and development due to its potential therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1071608-51-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,1,6,0 and 8 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1071608-51:
(9*1)+(8*0)+(7*7)+(6*1)+(5*6)+(4*0)+(3*8)+(2*5)+(1*1)=129
129 % 10 = 9
So 1071608-51-9 is a valid CAS Registry Number.
1071608-51-9Relevant articles and documents
Aromatic heterocyclic derivatives and applications of aromatic heterocyclic derivatives in medicines
-
, (2016/10/09)
The present invention discloses aromatic heterocyclic derivatives and applications of the aromatic heterocyclic derivatives in medicines, and specifically provides a class of aromatic heterocyclic compounds or stereoisomers, geometric isomers, tautomers, racemic bodies, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof, and pharmaceutical compositions containing the compounds. The present invention further discloses uses of the compounds or pharmaceutical compositions in drug preparation, wherein the drug is used for treatment of respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).
